Nephrocare Health IPO KPI Information
The Nephrocare Health IPO KPI (Key Performance Indicators) provide valuable insights into the company's financial efficiency, profitability, and capital utilization. Key metrics such as Return on Equity (ROE), Return on Capital Employed (ROCE), Debt-to-Equity Ratio, Return on Net Worth (RoNW), Price-to-Book Value (P/BV), and PAT Margin help investors evaluate the company's operational performance and financial health before investing in the IPO.
Based on the latest reported financial year (Mar 2025), Nephrocare Health Services Limited reported ROE of 13.45%, ROCE of 18.67%, RoNW of 13.19%, and PAT Margin of 8.88%. These key financial ratios provide investors with a snapshot of the company's profitability, capital efficiency, leverage, and overall financial strength.
Nephrocare Health IPO Key Performance Indicators
- Return on Equity (ROE): 13.45%
- Return on Capital Employed (ROCE): 18.67%
- Return on Net Worth (RoNW): 13.19%
- PAT Margin: 8.88%
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Nephrocare Health Services Limited KPI Information
| Particular | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ROE % | 13.45 | 8.76 | -3 |
| ROCE % | 18.67 | 10 | 0.44 |
| RoNW % | 13.19 | 8.69 | -3.02 |
| Pat Margin % | 8.88 | 6.21 | -2.7 |
Return Ratio
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Market Cap of Nephrocare Health Services Limited?
The post-IPO market capitalisation (market cap) of Nephrocare Health Services Limited is approximately ₹4,615.34 crore, based on the IPO issue price and the company's post-issue equity share capital. Market cap represents the total market value of a company's outstanding shares and is widely used by investors to assess the company's size and valuation.
What is the ROE of Nephrocare Health Services Limited?
Nephrocare Health Services Limited reported a Return on Equity (ROE) of 13.45% as of Mar 2025. ROE measures how efficiently the company generates profits from shareholders' equity. A higher ROE generally indicates strong financial performance and effective management of shareholder funds.
What is the ROCE of Nephrocare Health Services Limited?
The Return on Capital Employed (ROCE) of Nephrocare Health Services Limited stood at 18.67% as of Mar 2025. ROCE measures how efficiently the company uses its total capital to generate profits. A higher ROCE indicates better capital efficiency and operational performance.
What is the Net Profit Margin (PAT Margin) of Nephrocare Health Services Limited?
Nephrocare Health Services Limited reported a Profit After Tax (PAT) Margin of 8.88% as of Mar 2025. PAT Margin shows the percentage of revenue that remains as net profit after all operating expenses, interest, and taxes. A higher margin reflects better profitability and cost management.
What is the Return on Net Worth (RoNW) of Nephrocare Health Services Limited?
The Return on Net Worth (RoNW) of Nephrocare Health Services Limited was 13.19% as of Mar 2025. RoNW measures the company's ability to generate profits from shareholders' net worth and is an important indicator of overall financial efficiency.